ABVC Biopharma IncNASDAQ:ABVCNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5499
- TODAY'S CHANGE (%)-0.0175 (-3.0842%)
- Bid / Lots0.5300/ 10
- Ask / Lots0.5480/ 1
- Open / Previous Close0.5850 / 0.5674
- Day Range
- 52 Week Range
- Volume89,041
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABVC |
|---|---|---|
| 09:32 ET | 10482 | 0.5875 |
| 09:35 ET | 4360 | 0.5835 |
| 09:37 ET | 730 | 0.5835 |
| 09:39 ET | 171 | 0.5835 |
| 09:42 ET | 1779 | 0.586 |
| 09:44 ET | 600 | 0.587 |
| 09:46 ET | 172 | 0.5865 |
| 09:48 ET | 680 | 0.575 |
| 09:50 ET | 300 | 0.5801 |
| 09:51 ET | 320 | 0.58 |
| 09:53 ET | 200 | 0.5801 |
| 09:55 ET | 2300 | 0.58 |
| 10:00 ET | 2740 | 0.575 |
| 10:02 ET | 100 | 0.5751 |
| 10:04 ET | 5480 | 0.5751 |
| 10:06 ET | 6711 | 0.56 |
| 10:08 ET | 1695 | 0.55 |
| 10:09 ET | 100 | 0.55 |
| 10:11 ET | 100 | 0.55 |
| 10:13 ET | 100 | 0.55 |
| 10:15 ET | 100 | 0.55 |
| 10:18 ET | 100 | 0.55 |
| 10:20 ET | 100 | 0.55 |
| 10:22 ET | 290 | 0.55 |
| 10:24 ET | 100 | 0.55 |
| 10:26 ET | 100 | 0.55 |
| 10:27 ET | 380 | 0.55 |
| 10:29 ET | 770 | 0.561 |
| 10:33 ET | 320 | 0.55 |
| 10:36 ET | 100 | 0.55 |
| 10:38 ET | 200 | 0.55 |
| 10:40 ET | 100 | 0.55 |
| 10:42 ET | 100 | 0.55 |
| 10:44 ET | 220 | 0.55 |
| 10:45 ET | 690 | 0.55 |
| 10:49 ET | 380 | 0.55 |
| 10:51 ET | 100 | 0.55 |
| 10:54 ET | 100 | 0.55 |
| 10:56 ET | 100 | 0.55 |
| 11:00 ET | 200 | 0.55 |
| 11:03 ET | 690 | 0.55 |
| 11:05 ET | 410 | 0.55 |
| 11:07 ET | 910 | 0.55 |
| 11:09 ET | 260 | 0.55 |
| 11:12 ET | 230 | 0.55 |
| 11:14 ET | 290 | 0.55 |
| 11:16 ET | 1106 | 0.55 |
| 11:20 ET | 9548 | 0.545 |
| 11:21 ET | 1668 | 0.5401 |
| 11:23 ET | 532 | 0.5402 |
| 11:27 ET | 400 | 0.55 |
| 11:30 ET | 100 | 0.5401 |
| 11:36 ET | 200 | 0.545 |
| 11:38 ET | 130 | 0.54 |
| 11:39 ET | 100 | 0.5401 |
| 11:43 ET | 100 | 0.5401 |
| 11:48 ET | 590 | 0.54 |
| 11:50 ET | 1070 | 0.54 |
| 11:52 ET | 220 | 0.5401 |
| 11:54 ET | 100 | 0.5401 |
| 11:56 ET | 1371 | 0.5376 |
| 11:57 ET | 100 | 0.5364 |
| 11:59 ET | 100 | 0.5351 |
| 12:01 ET | 110 | 0.535 |
| 12:03 ET | 140 | 0.535 |
| 12:06 ET | 100 | 0.5351 |
| 12:08 ET | 210 | 0.535 |
| 12:12 ET | 100 | 0.5351 |
| 12:14 ET | 100 | 0.5351 |
| 12:17 ET | 140 | 0.535 |
| 12:24 ET | 100 | 0.535 |
| 12:28 ET | 100 | 0.535 |
| 12:32 ET | 100 | 0.5377 |
| 12:33 ET | 100 | 0.5375 |
| 12:35 ET | 300 | 0.5363 |
| 12:37 ET | 200 | 0.535 |
| 12:44 ET | 1159 | 0.54 |
| 12:48 ET | 220 | 0.54 |
| 12:50 ET | 140 | 0.54 |
| 12:51 ET | 100 | 0.54 |
| 12:57 ET | 120 | 0.54 |
| 01:06 ET | 100 | 0.5401 |
| 01:08 ET | 260 | 0.54 |
| 01:09 ET | 100 | 0.54 |
| 01:13 ET | 100 | 0.5401 |
| 01:18 ET | 100 | 0.54 |
| 01:22 ET | 186 | 0.5401 |
| 01:24 ET | 100 | 0.5401 |
| 01:27 ET | 200 | 0.54 |
| 01:31 ET | 100 | 0.54 |
| 01:33 ET | 310 | 0.54 |
| 01:38 ET | 100 | 0.5421 |
| 01:40 ET | 450 | 0.544 |
| 01:42 ET | 150 | 0.543 |
| 01:44 ET | 350 | 0.542 |
| 01:45 ET | 310 | 0.538 |
| 01:49 ET | 120 | 0.536 |
| 01:51 ET | 100 | 0.536 |
| 01:54 ET | 250 | 0.534 |
| 01:56 ET | 300 | 0.532 |
| 02:00 ET | 100 | 0.5334 |
| 02:05 ET | 100 | 0.532 |
| 02:07 ET | 300 | 0.532 |
| 02:12 ET | 100 | 0.5318 |
| 02:16 ET | 200 | 0.5318 |
| 02:20 ET | 210 | 0.53 |
| 02:25 ET | 200 | 0.53 |
| 02:27 ET | 100 | 0.53 |
| 02:30 ET | 362 | 0.53 |
| 02:39 ET | 100 | 0.53 |
| 02:41 ET | 100 | 0.53 |
| 02:48 ET | 370 | 0.53 |
| 02:50 ET | 220 | 0.53 |
| 02:52 ET | 140 | 0.53 |
| 02:54 ET | 100 | 0.53 |
| 02:57 ET | 100 | 0.53 |
| 02:59 ET | 100 | 0.53 |
| 03:03 ET | 100 | 0.53 |
| 03:06 ET | 110 | 0.53 |
| 03:14 ET | 100 | 0.53 |
| 03:21 ET | 238 | 0.53 |
| 03:24 ET | 100 | 0.53 |
| 03:26 ET | 102 | 0.53 |
| 03:32 ET | 100 | 0.53 |
| 03:37 ET | 100 | 0.53 |
| 03:39 ET | 100 | 0.53 |
| 03:44 ET | 795 | 0.53 |
| 03:48 ET | 200 | 0.53 |
| 03:50 ET | 100 | 0.53 |
| 03:51 ET | 200 | 0.53 |
| 03:53 ET | 100 | 0.53 |
| 03:57 ET | 989 | 0.5406 |
| 04:00 ET | 1411 | 0.5499 |
Nov 14, 2024
*DJ ABVC BioPharma 3Q >ABVC, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
9:00AM ET on Thursday Nov 14, 2024 by Dow JonesABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ABVC Biopharma Inc | 7.4M | -0.6x | --- |
Virax Biolabs Group Ltd | 7.7M | -0.6x | --- |
Cannabis Bioscience International Holdings Inc | 7.4M | -13.0x | --- |
Alterity Therapeutics Ltd | 10.4M | -0.5x | --- |
Evaxion Biotech A/S | 7.8M | -0.1x | --- |
Cardio Diagnostics Holdings Inc | 7.5M | -0.6x | --- |
Company Information
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1519 is used for the treatment of non-small cell lung cancer. ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. The Company develops drugs and medical devices derived from plants.
Contact Information
- Headquarters
- 44370 Old Warm Springs BlvdFREMONT, CA, United States 94538-6148
- Phone
- 510-668-0881
- Fax
- ---
Executives
- Chairman of the Board, Chief Business Officer
- Eugene Jiang
- Chief Executive Officer, Interim Chief Financial Officer
- Uttam Patil
- Chief Scientific Officer, Chief Strategy Officer, Director
- Tsung-Shann Jiang
- Director
- Chang-Jen Jiang
- Director
- Shuling Jiang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.1M |
|---|---|
Revenue (TTM) | $509.8K |
Shares Outstanding | 13.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-0.97 |
Book Value | $1.06 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 14.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,242.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
